Business Context and Reporting Period
This Form 8-K filing by Globus Medical, Inc. (Delaware) was submitted on January 24, 2013. The report details the approval of executive compensation under the 2012 Executive Performance Bonus Plan and the adoption of the 2013 Executive Performance Bonus Plan by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation figures.
- 2012 Bonus Payments Approved:
- David C. Paul (Chairman and CEO): $624,731
- David M. Demski (President and COO): $458,136
- Richard A. Baron (SVP and CFO): $268,925
- A. Brett Murphy (EVP, U.S. Sales): $320,375
Material Changes
The filing reports the formal approval of cash bonuses for the fiscal year ended December 31, 2012, and the establishment of a new performance-based bonus structure for 2013. No material changes to financial performance or corporate structure are reported in this document.
Guidance, Outlook, and Management Commentary
The 2013 Executive Performance Bonus Plan ties executive compensation directly to the Company's 2013 sales revenue performance:
- Threshold: Bonuses are contingent on 2013 sales revenue exceeding a threshold level set by the Committee.
- Target: If the target sales revenue is achieved, officers receive their target bonus.
- Exceeding Target: If sales exceed the target, bonuses are adjusted using multipliers based on specified revenue levels.
- Calculation Basis: Target bonuses for most officers are based on their actual 2012 cash bonus. For Richard A. Baron, the target is his 2012 bonus less a $100,000 discretionary increase granted in 2012.
- Discretion: The Committee retains the right to apply individual performance modifiers to increase or decrease final payments.
Important Facts for Investor Verification
- Verify the specific sales revenue thresholds and multipliers for the 2013 Bonus Plan, as these are not disclosed in this filing.
- Confirm the total cash outflow for the 2012 bonuses ($1,672,167) against the company's cash flow statement in the most recent 10-K.
- Monitor future 8-K filings or 10-Q reports to see if the 2013 sales targets were met and the resulting bonus payouts.
- Note that the filing does not provide a clear value for the company's overall 2012 or 2013 financial performance.